dr. reddy's labs glp-1 receptor agonists weight management diabetes treatments agonist A Comprehensive Review of the Current Insights, Advantages and Challenges

Remember: Constipation is a common side effect of GLP-1 agonists, but it's manageable with the right strategies

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

With the participation of researchers from the Paul Langerhans Institute Dresden (PLID), partner at the German Center for Diabetes Research, a GLP-1 receptor agonist in the form of tablets could for the first time be compared with the most common second-line therapy of T2D, a DPP-IV inhibitor

The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity

Supports gut lining integrity

Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases